Alumis (ALMS) Equity Average (2023 - 2025)
Alumis (ALMS) reported Equity Average of $343.0 million for Q4 2025, up 12.75% year-over-year from $304.2 million in Q4 2024, and down 21.15% quarter-over-quarter from $435.0 million in Q3 2025.
Alumis (ALMS) Equity Average (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Equity Average data on file, last reported at $343.0 million in Q4 2025.
- Equity Average for Q4 2025 came in at $343.0 million, up 12.75% year-over-year; the trailing twelve-month figure through Dec 2025 was $343.0 million (up 12.75% YoY), and the FY2025 annual result was $280.7 million, up 809.23% from the prior year.
- Equity Average declined to $343.0 million in Q4 2025 per ALMS's latest filing, from $435.0 million in the prior quarter.
- Over five years, Equity Average peaked at $435.0 million in Q3 2025 and troughed at -$412.3 million in Q2 2024.
- A 3-year average of $19.9 million and a median of $84.5 million in 2024 frame the typical range for Equity Average.
- On a YoY basis, Equity Average climbed as much as 1062.86% in 2025 and fell as far as 12.75% in 2025.
- A 3-year view of Equity Average shows it stood at -$321.2 million in 2023, then surged by 194.73% to $304.2 million in 2024, then climbed by 12.75% to $343.0 million in 2025.
- Business Quant data shows ALMS's Equity Average at $343.0 million in Q4 2025, $435.0 million in Q3 2025, and $326.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | 343.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 343.04 Mn |
| Sep 30, 2025 | 435.05 Mn |
| Jun 30, 2025 | 326.82 Mn |
| Mar 31, 2025 | 214.21 Mn |
| Dec 31, 2024 | 304.25 Mn |
| Sep 30, 2024 | -45.18 Mn |
| Jun 30, 2024 | -412.34 Mn |
| Mar 31, 2024 | -362.59 Mn |
| Dec 31, 2023 | -321.17 Mn |
| Sep 30, 2023 | -282.71 Mn |